Medicare Enrolled
Dr. Shalin Shah, M.D.
Cardiovascular Disease · Tampa, FL
Practice pattern: Electrophysiology & Remote
— Practice combining electrophysiology and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shah
Dr. Shalin Shah is a cardiovascular disease specialist in Tampa, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Shah performed 1,651 Medicare services across 1,195 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shah received a total of $18,174 from 36 pharmaceutical and/or device companies across 177 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ 1,651 Medicare services
$18,174 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 97804 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗1,651
Medicare services
Bottom 39% in FL for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
1,195
Unique beneficiaries
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~83 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
296 | $10 | $35 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
217 | $92 | $257 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
141 | $129 | $437 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
98 | $135 | $498 |
| New patient office visit, complex (60-74 min) | 81 | $158 | $540 |
| Catheter ablation for abnormal heart rhythm A procedure where catheters are inserted to destroy tissue causing irregular heartbeats. |
76 | $251 | $827 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
73 | $16 | $53 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
72 | $57 | $191 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
71 | $19 | $65 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
65 | $63 | $179 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
65 | $26 | $86 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
60 | $93 | $310 |
| Heart rhythm stimulator programming after drug infusion Adjustment of a heart rhythm stimulation device following a drug infusion. This procedure involves reprogramming the device settings to ensure proper function after the medication has been administered. |
55 | $65 | $258 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
53 | $23 | $73 |
| Heart chamber tissue destruction via catheter A procedure that destroys tissue in the upper heart chamber using a tube to treat abnormal heart rhythm. |
47 | $251 | $826 |
| Atrial fibrillation ablation with pulmonary vein isolation A procedure to treat atrial fibrillation by mapping the heart's electrical activity and destroying tissue causing irregular contractions. This is done by isolating the pulmonary veins using catheter-based destruction. |
46 | $769 | $2,970 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
24 | $27 | $90 |
| Pacemaker insertion with heart chamber electrodes A surgical procedure to implant a pacemaker device and place electrodes into the upper and lower chambers of the heart to regulate heart rhythm. |
22 | $342 | $1,378 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
21 | $76 | $239 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
20 | $18 | $63 |
| Repair of left upper heart chamber with implant A surgical procedure to repair the left upper chamber of the heart using an implanted device, with review by a radiologist. |
13 | $637 | $1,942 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
12 | $8 | $28 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
12 | $18 | $58 |
| Removal and replacement of dual lead permanent pacemaker This procedure involves removing an existing permanent pacemaker with two leads and replacing it with a new device. It is performed to update or repair the heart rhythm management system. |
11 | $255 | $940 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
30.3% high complexity
0.0% medium
69.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,174
Total received (2018-2024)
Avg $2,596/year across 7 years
Top 15% in FL for cardiovascular disease
36
Companies
177
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,907 (54.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,267 (45.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,403
2023
$1,118
2022
$2,487
2021
$1,236
2020
$2,692
2019
$3,151
2018
$6,087
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$8,204
Biosense Webster, Inc.
$3,172
Boston Scientific Corporation
$2,224
Acutus Medical, Inc.
$1,214
Medical Device Business Services, Inc.
$888
Medtronic, Inc.
$519
Medtronic Vascular, Inc.
$227
Kestra Medical Technology Services, Inc.
$225
CVRx, Inc.
$184
Impulse Dynamics (USA) Inc.
$153
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$133
E.R. Squibb & Sons, L.L.C.
$118
BIOTRONIK INC.
$109
TESARO, Inc.
$75
BOSTON SCIENTIFIC CORPORATION
$68
Amgen Inc.
$68
Mirati Therapeutics, Inc.
$65
Merck Sharp & Dohme LLC
$59
ATRICURE, INC.
$52
Myriad Genetic Laboratories, Inc.
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$38
Inari Medical, Inc.
$35
Takeda Pharmaceuticals U.S.A., Inc.
$33
Genentech USA, Inc.
$28
Gilead Sciences, Inc.
$26
MEDIVATION FIELD SOLUTIONS LLC
$26
Legend Biotech USA Inc.
$23
SANOFI-AVENTIS U.S. LLC
$23
Apellis Pharmaceuticals, Inc.
$22
Braemar Manufacturing, LLC
$21
CHF Solutions, Inc
$17
Elutia, Inc.
$16
CSL Behring
$16
AstraZeneca Pharmaceuticals LP
$15
Novartis Pharmaceuticals Corporation
$15
Kiniksa Pharmaceuticals, Ltd.
$14
Top 3 companies account for 74.8% of total payments
Associated products mentioned in payments ›
3F · AGILIS · AMPLATZER · AMPLATZER AMULET · ATTAIN COMMAND + SUREVALVE · Acticor 7 VR-T DX · Adapta · Afstyla · Allure CRT Pacemaker · Aquadex · Arcalyst · Assure WCD · Azure · Barostim Neo System · CAMZYOS · CARTO 3 · COBALT DR MRI SURESCAN · CRT-Ps · Cardiac Monitoring Suite · CardioMEMS HF System · Carto 3 System · ECM Patch · ELIQUIS · ENSITE · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edora · Empaveli · Endurity Pacemaker · Ensite Cardiac Mapping System · FLOWTRIEVER CATHETER · FRUZAQLA · GENERAL THERAPIES · GENERAL STRUCTURAL HEART · General - Ultrasound · HEMLIBRA · INTELLAMAP ORION · JARDIANCE · KRAZATI · LATITUDE · LEQVIO · LYNPARZA · LifeVest · MICRA · MULTAQ · MYCARELINK · MYRISK · Micra · Mitra Clip system · OCTARAY MAPPING CATHETER · Optimizer · PERCLOSE PROSTYLE · Pacemakers · Pouch · QDOT MICRO Catheter · RESONATE · RESONATE EL ICD VR · Repatha · Reveal LINQ · Rhythmia Mapping System · S · S-ICD · VERQUVO · Visitag · WATCHMAN · XTANDI · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (54%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $1,101 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
236
Per 100K population
15.8
County median income
$75,011
Nearest hospital
AdventHealth Carrollwood
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Shah is an electrophysiology & remote specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 15% of FL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Shah experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Shah performed 296 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $18,174 from 36 companies across 177 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other cardiologists in Tampa?
Dr. Shah's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Tampa
Browse cardiologists in Tampa ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in FL
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in FL
Which FL cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Biosense Webster, Inc. Payments to Doctors
See all physicians who received payments from Biosense Webster, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology